galactosamine has been researched along with apigenin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, F; Wang, JL; Xie, ML; Ye, H; Zhou, RJ | 1 |
| Hu, JJ; Lin, MX; Pan, CW; Wang, H | 1 |
| Fan, K; Xie, ML; Zhao, Y; Zhou, RJ | 1 |
3 other study(ies) available for galactosamine and apigenin
| Article | Year |
|---|---|
Apigenin inhibits d-galactosamine/LPS-induced liver injury through upregulation of hepatic Nrf-2 and PPARγ expressions in mice.
Topics: Administration, Oral; Animals; Apigenin; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Galactosamine; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; PPAR gamma; Reactive Oxygen Species; Treatment Outcome; Up-Regulation | 2017 |
Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
Topics: Animals; Apigenin; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Galactosamine; Gene Expression Regulation; Heme Oxygenase-1; Lipopolysaccharides; Liver; Liver Function Tests; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oryza; Phosphorylation; Plant Extracts; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation | 2018 |
Protective effect of apigenin on d-galactosamine/LPS-induced hepatocellular injury by increment of Nrf-2 nucleus translocation.
Topics: Active Transport, Cell Nucleus; Anilides; Animals; Apigenin; Cell Nucleus; Cells, Cultured; Chemical and Drug Induced Liver Injury; Galactosamine; Heptanoic Acids; Lipopolysaccharides; NF-E2-Related Factor 2; NF-kappa B; PPAR gamma; Rats | 2020 |